Search Results

Societal CDMO, Inc. announced that it has entered into a definitive agreement with CoreRx, Inc. under which CoreRx will acquire Societal CDMO.

CoreRx, Inc. announced that it has completed its acquisition of Societal CDMO, Inc., a contract development and manufacturing organization dedicated to solving complex formulation and manufacturing challenges primarily focused on small molecule therapeutics.

Signet Healthcare Partners and Bionpharma Inc today announced the sale of CoreRx, a global contract development and manufacturing organization (“CDMO”). Following the sale to private equity firm NovaQuest Private Equity, Signet Healthcare Partners will retain a meaningful equity stake in CoreRx. The terms of the transaction are not disclosed. Based in Clearwater, FL, CoreRx is a leading provider of clinical and commercial CDMO services to a wide ra

Bend Bioscience and QHP Capital (“QHP”), the management company for NovaQuest Private Equity (“NQPE”), have announced plans to invest in a new operation in Bend, Oregon , an emerging hub of biotechnology R&D and manufacturing.

JanOne’s lead drug clinical candidate TV1001SR to treat PAD and associated pain will be manufactured by CoreRX Pharma with phase 2b trials expected to begin Q4 2020

As part of CoreRx, Inc’s growth in expanding its cGMP manufacturing capabilities to support niche commercial products, we are pleased to announce the completed installation of the Optel Line Master Serialization and Aggregation System for support of commercial liquid dosage form manufacturing.